NDC 10702-055 – Hydrocodone Bitartrate and Homatropine Methylbromide
Hydrocodone Bitartrate 5 mg/1; Homatropine Methylbromide 1.5 mg/1 · Tablet · Oral
Product NDC10702-055
Product details
- Brand name
- Hydrocodone Bitartrate and Homatropine Methylbromide
- Generic name
- Hydrocodone Bitartrate and Homatropine Methylbromide
- Labeler
- KVK-Tech, Inc.
- Dosage form
- Tablet
- Route
- Oral
- Marketing category
- ANDA · ANDA207176
- Marketed since
- August 7, 2017
- Listing expires
- December 31, 2027
- Pharmacologic class
- Opioid Agonist
Active ingredients
- Hydrocodone Bitartrate 5 mg/1
- Homatropine Methylbromide 1.5 mg/1
Uses, dosage, side effects and warnings for Hydrocodone Bitartrate and Homatropine Methylbromide →
Package NDC codes (4)
| Package NDC | Description | Since |
|---|---|---|
| 10702-055-01 | 100 TABLET in 1 BOTTLE (10702-055-01) | Aug 7, 2017 |
| 10702-055-03 | 30 TABLET in 1 BOTTLE (10702-055-03) | Aug 7, 2017 |
| 10702-055-09 | 90 TABLET in 1 BOTTLE (10702-055-09) | Aug 7, 2017 |
| 10702-055-10 | 1000 TABLET in 1 BOTTLE (10702-055-10) | Aug 7, 2017 |
Recalls mentioning this NDC
- D-0386-2021 May 26, 2021 · Class III
Failed Impurities/Degradation Specifications
Other Hydrocodone Bitartrate and Homatropine Methylbromide products
- 64950-206 Hydrocodone Bitartrate 5 mg/1; Homatropine Methylbromide 1.5 mg/1 · Tablet · Genus Lifesciences Inc.
- 43386-118 Hydrocodone Bitartrate 5 mg/1; Homatropine Methylbromide 1.5 mg/1 · Tablet · Lupin Pharmaceuticals,Inc.
- 40032-118 Hydrocodone Bitartrate 5 mg/1; Homatropine Methylbromide 1.5 mg/1 · Tablet · Novel Laboratories, Inc.
- 64950-371 Hydrocodone Bitartrate 5 mg/5mL; Homatropine Methylbromide 1.5 mg/5mL · Solution · Genus Lifesciences Inc.
- 10702-150 Hydrocodone Bitartrate 5 mg/5mL; Homatropine Methylbromide 1.5 mg/5mL · Liquid · KVK-Tech, Inc.
- 40032-810 Hydrocodone Bitartrate 5 mg/5mL; Homatropine Methylbromide 1.5 mg/5mL · Syrup · Novel Laboratories, Inc.
- 0121-1036 Hydrocodone Bitartrate 5 mg/5mL; Homatropine Methylbromide 1.5 mg/5mL · Solution · PAI Holdings, LLC dba PAI Pharma